Skip to main content
Erschienen in: Head and Neck Pathology 2/2022

19.08.2021 | Original Paper

Sclerosing Polycystic Adenoma: Conclusive Clinical and Molecular Evidence of Its Neoplastic Nature

verfasst von: Juan C. Hernandez-Prera, Daryoush Saeed-Vafa, Amin Heidarian, Kathleen Gewandter, Kristen Otto, Bruce M. Wenig

Erschienen in: Head and Neck Pathology | Ausgabe 2/2022

Einloggen, um Zugang zu erhalten

Abstract

Sclerosing polycystic adenosis, initially considered a non-neoplastic salivary gland lesion and classified as such in the 2017 WHO Classification of Head and Neck Tumors, has been the subject of controversy regarding its possible neoplastic nature. The reporting of recurrent PI3K pathway alteration represents evidence to support these lesions as being neoplastic and more appropriately referred to as sclerosing polycystic adenoma (SPA). Herein, we provide additional evidence that supports the classification of SPA as a true neoplasm. Eight cases of SPA were identified in our database and consultation files. All cases were subjected to PTEN immunohistochemistry (IHC) and next-generation sequencing (NGS). In addition, one patient underwent genetic counseling and germline testing. The cases included 5 men and 3 women with a mean age of 41 years (range 11–78) and all tumors arose in the parotid gland. One patient had multiple recurrences over a period of 2 years. Morphologically the tumors were circumscribed and characterized by an admixture of acini, ducts and cysts embedded in a fibrotic/sclerotic stroma. The cells lining the ducts and cysts showed variable granular, vacuolated, foamy and apocrine cytoplasmic features, as well as acinar cells contained intracytoplasmic brightly eosinophilic granules. The apocrine intraductal proliferations showed mild to moderate atypia in 6 cases. One case showed overt malignant morphology that ranged from intraductal carcinoma to invasive salivary duct carcinoma. Seven cases tested for PTEN IHC showed loss of nuclear expression in the acinar and ductal cells with retained PTEN expression in the myoepithelial cell and stroma. NGS detected PIK3CA or PIK3R1 genetic alterations in 7 cases, including a novel TFG-PIK3CA fusion. Coexisting PTEN mutations were seen in 4 cases, including in a patient with clinical stigmata of Cowden syndrome and confirmed by germline genetic testing. Our findings herein documented including recurrence of tumor, malignant transformation, high prevalence of PI3K pathway oncogenic alterations and the possible heretofore undescribed association with Cowden syndrome add support to classifying SPA as true neoplasms justifying their designation as adenoma, rather than adenosis.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Smith BC, Ellis GL, Slater LJ, Foss RD. Sclerosing polycystic adenosis of major salivary glands., A clinicopathologic analysis of nine cases. Am J Surg Pathol. 1996;20(2):161–70.PubMedCrossRef Smith BC, Ellis GL, Slater LJ, Foss RD. Sclerosing polycystic adenosis of major salivary glands., A clinicopathologic analysis of nine cases. Am J Surg Pathol. 1996;20(2):161–70.PubMedCrossRef
2.
Zurück zum Zitat Skalova A, Michal M, Simpson R, Starek I, Přádná J, Pfaltz M. Sclerosing polycystic adenosis of parotid gland with dysplasia and ductal carcinoma in situ. Virchows Arch. 2002;440(1):29–35.PubMedCrossRef Skalova A, Michal M, Simpson R, Starek I, Přádná J, Pfaltz M. Sclerosing polycystic adenosis of parotid gland with dysplasia and ductal carcinoma in situ. Virchows Arch. 2002;440(1):29–35.PubMedCrossRef
3.
Zurück zum Zitat Gnepp DR. Sclerosing polycystic adenosis of the salivary gland: a lesion that may be associated with dysplasia and carcinoma in situ: on: sclerosing polycystic adenosis of parotid gland with dysplasia and ductal carcinoma in situ: report of three cases with immunohistochemical and ultrastructural examination. Skalova A, Michal M, Simpson RHW, et al. Virchows Arch 2002. Adv Anatomic Pathol. 2003;10(4):218–22.CrossRef Gnepp DR. Sclerosing polycystic adenosis of the salivary gland: a lesion that may be associated with dysplasia and carcinoma in situ: on: sclerosing polycystic adenosis of parotid gland with dysplasia and ductal carcinoma in situ: report of three cases with immunohistochemical and ultrastructural examination. Skalova A, Michal M, Simpson RHW, et al. Virchows Arch 2002. Adv Anatomic Pathol. 2003;10(4):218–22.CrossRef
4.
Zurück zum Zitat Gnepp DR, Wang LJ, Brandwein-Gensler M, Slootweg P, Gill M, Hille J. Sclerosing polycystic adenosis of the salivary gland: a report of 16 cases. Am J Surg Pathol. 2006;30(2):154–64.PubMedCrossRef Gnepp DR, Wang LJ, Brandwein-Gensler M, Slootweg P, Gill M, Hille J. Sclerosing polycystic adenosis of the salivary gland: a report of 16 cases. Am J Surg Pathol. 2006;30(2):154–64.PubMedCrossRef
5.
Zurück zum Zitat Skálová A, Gnepp DR, Simpson RH, Lewis JE, Janssen D, Sima R, et al. Clonal nature of sclerosing polycystic adenosis of salivary glands demonstrated by using the polymorphism of the human androgen receptor (HUMARA) locus as a marker. Am J Surg Pathol. 2006;30(8):939–44.PubMedCrossRef Skálová A, Gnepp DR, Simpson RH, Lewis JE, Janssen D, Sima R, et al. Clonal nature of sclerosing polycystic adenosis of salivary glands demonstrated by using the polymorphism of the human androgen receptor (HUMARA) locus as a marker. Am J Surg Pathol. 2006;30(8):939–44.PubMedCrossRef
6.
Zurück zum Zitat Marques RC, Félix A. Invasive carcinoma arising from sclerosing polycystic adenosis of the salivary gland. Virchows Arch. 2014;464(5):621–5.CrossRef Marques RC, Félix A. Invasive carcinoma arising from sclerosing polycystic adenosis of the salivary gland. Virchows Arch. 2014;464(5):621–5.CrossRef
7.
Zurück zum Zitat Seethala R, Gnepp DR, Skalova A, Slater L, Williams MD. Sclerosing polycystic adenosis. In: El-Naggar AKCJ, Grandis JR, Takata T, Slootweg PJ, editors. WHO classification of head and neck tumours. 4th ed. Lyon: IARC Press; 2017. p. 195. Seethala R, Gnepp DR, Skalova A, Slater L, Williams MD. Sclerosing polycystic adenosis. In: El-Naggar AKCJ, Grandis JR, Takata T, Slootweg PJ, editors. WHO classification of head and neck tumours. 4th ed. Lyon: IARC Press; 2017. p. 195.
8.
Zurück zum Zitat Bishop JA, Gagan J, Baumhoer D, McLean-Holden AL, Oliai BR, Couce M, et al. Sclerosing polycystic “adenosis” of salivary glands: a neoplasm characterized by PI3K pathway alterations more correctly named sclerosing polycystic adenoma. Head Neck Pathol. 2020;14(3):630–6.PubMedCrossRef Bishop JA, Gagan J, Baumhoer D, McLean-Holden AL, Oliai BR, Couce M, et al. Sclerosing polycystic “adenosis” of salivary glands: a neoplasm characterized by PI3K pathway alterations more correctly named sclerosing polycystic adenoma. Head Neck Pathol. 2020;14(3):630–6.PubMedCrossRef
9.
Zurück zum Zitat Boyle TA, Mondal AK, Saeed-Vafa D, Ananth S, Ahluwalia P, Kothapalli R, et al. Guideline-adherent clinical validation of a comprehensive 170-gene DNA/RNA Panel for determination of small variants, copy number variations, splice variants, and fusions on a next-generation sequencing platform in the CLIA setting. Front Genet. 2021;12:503830.PubMedPubMedCentralCrossRef Boyle TA, Mondal AK, Saeed-Vafa D, Ananth S, Ahluwalia P, Kothapalli R, et al. Guideline-adherent clinical validation of a comprehensive 170-gene DNA/RNA Panel for determination of small variants, copy number variations, splice variants, and fusions on a next-generation sequencing platform in the CLIA setting. Front Genet. 2021;12:503830.PubMedPubMedCentralCrossRef
11.
Zurück zum Zitat Arcaro A, Guerreiro AS. The phosphoinositide 3-kinase pathway in human cancer: genetic alterations and therapeutic implications. Curr Genomics. 2007;8(5):271–306.PubMedPubMedCentralCrossRef Arcaro A, Guerreiro AS. The phosphoinositide 3-kinase pathway in human cancer: genetic alterations and therapeutic implications. Curr Genomics. 2007;8(5):271–306.PubMedPubMedCentralCrossRef
12.
13.
Zurück zum Zitat Vivanco I, Sawyers CL. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer. 2002;2(7):489–501.PubMedCrossRef Vivanco I, Sawyers CL. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer. 2002;2(7):489–501.PubMedCrossRef
15.
Zurück zum Zitat Guo S, Loibl S, von Minckwitz G, Darb-Esfahani S, Lederer B, Denkert C. PIK3CA H1047R mutation associated with a lower pathological complete response rate in triple-negative breast cancer patients treated with anthracycline-taxane-based neoadjuvant chemotherapy. Cancer Res Treat. 2020;52(3):689–96.PubMedPubMedCentralCrossRef Guo S, Loibl S, von Minckwitz G, Darb-Esfahani S, Lederer B, Denkert C. PIK3CA H1047R mutation associated with a lower pathological complete response rate in triple-negative breast cancer patients treated with anthracycline-taxane-based neoadjuvant chemotherapy. Cancer Res Treat. 2020;52(3):689–96.PubMedPubMedCentralCrossRef
16.
Zurück zum Zitat Stransky N, Cerami E, Schalm S, Kim JL, Lengauer C. The landscape of kinase fusions in cancer. Nat Commun. 2014;5:4846.PubMedCrossRef Stransky N, Cerami E, Schalm S, Kim JL, Lengauer C. The landscape of kinase fusions in cancer. Nat Commun. 2014;5:4846.PubMedCrossRef
17.
Zurück zum Zitat Beetz C, Johnson A, Schuh AL, Thakur S, Varga RE, Fothergill T, et al. Inhibition of TFG function causes hereditary axon degeneration by impairing endoplasmic reticulum structure. Proc Natl Acad Sci USA. 2013;110(13):5091–6.PubMedPubMedCentralCrossRef Beetz C, Johnson A, Schuh AL, Thakur S, Varga RE, Fothergill T, et al. Inhibition of TFG function causes hereditary axon degeneration by impairing endoplasmic reticulum structure. Proc Natl Acad Sci USA. 2013;110(13):5091–6.PubMedPubMedCentralCrossRef
18.
Zurück zum Zitat Mencinger M, Panagopoulos I, Andreasson P, Lassen C, Mitelman F, Aman P. Characterization and chromosomal mapping of the human TFG gene involved in thyroid carcinoma. Genomics. 1997;41(3):327–31.PubMedCrossRef Mencinger M, Panagopoulos I, Andreasson P, Lassen C, Mitelman F, Aman P. Characterization and chromosomal mapping of the human TFG gene involved in thyroid carcinoma. Genomics. 1997;41(3):327–31.PubMedCrossRef
19.
Zurück zum Zitat Greco A, Mariani C, Miranda C, Lupas A, Pagliardini S, Pomati M, et al. The DNA rearrangement that generates the TRK-T3 oncogene involves a novel gene on chromosome 3 whose product has a potential coiled-coil domain. Mol Cell Biol. 1995;15(11):6118–27.PubMedPubMedCentralCrossRef Greco A, Mariani C, Miranda C, Lupas A, Pagliardini S, Pomati M, et al. The DNA rearrangement that generates the TRK-T3 oncogene involves a novel gene on chromosome 3 whose product has a potential coiled-coil domain. Mol Cell Biol. 1995;15(11):6118–27.PubMedPubMedCentralCrossRef
20.
Zurück zum Zitat Hisaoka M, Ishida T, Imamura T, Hashimoto H. TFG is a novel fusion partner of NOR1 in extraskeletal myxoid chondrosarcoma. Genes Chromosomes Cancer. 2004;40(4):325–8.PubMedCrossRef Hisaoka M, Ishida T, Imamura T, Hashimoto H. TFG is a novel fusion partner of NOR1 in extraskeletal myxoid chondrosarcoma. Genes Chromosomes Cancer. 2004;40(4):325–8.PubMedCrossRef
22.
Zurück zum Zitat Salvesen HB, MacDonald N, Ryan A, Jacobs IJ, Lynch ED, Akslen LA, et al. PTEN methylation is associated with advanced stage and microsatellite instability in endometrial carcinoma. Int J Cancer. 2001;91(1):22–6.PubMedCrossRef Salvesen HB, MacDonald N, Ryan A, Jacobs IJ, Lynch ED, Akslen LA, et al. PTEN methylation is associated with advanced stage and microsatellite instability in endometrial carcinoma. Int J Cancer. 2001;91(1):22–6.PubMedCrossRef
23.
Zurück zum Zitat Goel A, Arnold CN, Niedzwiecki D, Carethers JM, Dowell JM, Wasserman L, et al. Frequent inactivation of PTEN by promoter hypermethylation in microsatellite instability-high sporadic colorectal cancers. Cancer Res. 2004;64(9):3014–21.PubMedCrossRef Goel A, Arnold CN, Niedzwiecki D, Carethers JM, Dowell JM, Wasserman L, et al. Frequent inactivation of PTEN by promoter hypermethylation in microsatellite instability-high sporadic colorectal cancers. Cancer Res. 2004;64(9):3014–21.PubMedCrossRef
24.
Zurück zum Zitat Zhang S, Yu D. PI(3)king apart PTEN’s role in cancer. Clin Cancer Res. 2010;16(17):4325–30.PubMedCrossRef Zhang S, Yu D. PI(3)king apart PTEN’s role in cancer. Clin Cancer Res. 2010;16(17):4325–30.PubMedCrossRef
25.
Zurück zum Zitat Djordjevic B, Hennessy BT, Li J, Barkoh BA, Luthra R, Mills GB, et al. Clinical assessment of PTEN loss in endometrial carcinoma: immunohistochemistry outperforms gene sequencing. Mod Pathol. 2012;25(5):699–708.PubMedPubMedCentralCrossRef Djordjevic B, Hennessy BT, Li J, Barkoh BA, Luthra R, Mills GB, et al. Clinical assessment of PTEN loss in endometrial carcinoma: immunohistochemistry outperforms gene sequencing. Mod Pathol. 2012;25(5):699–708.PubMedPubMedCentralCrossRef
26.
Zurück zum Zitat Uemura A, Bandoh N, Goto T, Sato R, Suzuki S, Kubota A, et al. Sclerosing polycystic adenosis arising in the parotid gland without PI3K pathway mutations. Head Neck Pathol. 2021. Uemura A, Bandoh N, Goto T, Sato R, Suzuki S, Kubota A, et al. Sclerosing polycystic adenosis arising in the parotid gland without PI3K pathway mutations. Head Neck Pathol. 2021.
27.
Zurück zum Zitat Park SW, Kang MR, Eom HS, Han JY, Ahn CH, Kim SS, et al. Somatic mutation of PIK3R1 gene is rare in common human cancers. Acta Oncol. 2010;49(1):125–7.PubMedCrossRef Park SW, Kang MR, Eom HS, Han JY, Ahn CH, Kim SS, et al. Somatic mutation of PIK3R1 gene is rare in common human cancers. Acta Oncol. 2010;49(1):125–7.PubMedCrossRef
28.
Zurück zum Zitat Samuels Y, Wang Z, Bardelli A, Silliman N, Ptak J, Szabo S, et al. High frequency of mutations of the PIK3CA gene in human cancers. Science. 2004;304(5670):554.PubMedCrossRef Samuels Y, Wang Z, Bardelli A, Silliman N, Ptak J, Szabo S, et al. High frequency of mutations of the PIK3CA gene in human cancers. Science. 2004;304(5670):554.PubMedCrossRef
30.
Zurück zum Zitat Nardi V, Sadow PM, Juric D, Zhao D, Cosper AK, Bergethon K, et al. Detection of novel actionable genetic changes in salivary duct carcinoma helps direct patient treatment. Clin Cancer Res. 2013;19(2):480–90.PubMedCrossRef Nardi V, Sadow PM, Juric D, Zhao D, Cosper AK, Bergethon K, et al. Detection of novel actionable genetic changes in salivary duct carcinoma helps direct patient treatment. Clin Cancer Res. 2013;19(2):480–90.PubMedCrossRef
31.
Zurück zum Zitat Griffith CC, Seethala RR, Luvison A, Miller M, Chiosea SI. PIK3CA mutations and PTEN loss in salivary duct carcinomas. Am J Surg Pathol. 2013;37(8):1201–7.PubMedCrossRef Griffith CC, Seethala RR, Luvison A, Miller M, Chiosea SI. PIK3CA mutations and PTEN loss in salivary duct carcinomas. Am J Surg Pathol. 2013;37(8):1201–7.PubMedCrossRef
32.
Zurück zum Zitat Saintigny P, Mitani Y, Pytynia KB, Ferrarotto R, Roberts DB, Weber RS, et al. Frequent PTEN loss and differential HER2/PI3K signaling pathway alterations in salivary duct carcinoma: Implications for targeted therapy. Cancer. 2018;124(18):3693–705.PubMedCrossRef Saintigny P, Mitani Y, Pytynia KB, Ferrarotto R, Roberts DB, Weber RS, et al. Frequent PTEN loss and differential HER2/PI3K signaling pathway alterations in salivary duct carcinoma: Implications for targeted therapy. Cancer. 2018;124(18):3693–705.PubMedCrossRef
33.
Zurück zum Zitat Chiosea SI, Williams L, Griffith CC, Thompson LD, Weinreb I, Bauman JE, et al. Molecular characterization of apocrine salivary duct carcinoma. Am J Surg Pathol. 2015;39(6):744–52.PubMedCrossRef Chiosea SI, Williams L, Griffith CC, Thompson LD, Weinreb I, Bauman JE, et al. Molecular characterization of apocrine salivary duct carcinoma. Am J Surg Pathol. 2015;39(6):744–52.PubMedCrossRef
34.
Zurück zum Zitat Weinreb I, Bishop JA, Chiosea SI, Seethala RR, Perez-Ordonez B, Zhang L, et al. Recurrent RET gene rearrangements in intraductal carcinomas of salivary gland. Am J Surg Pathol. 2018;42(4):442–52.PubMedPubMedCentralCrossRef Weinreb I, Bishop JA, Chiosea SI, Seethala RR, Perez-Ordonez B, Zhang L, et al. Recurrent RET gene rearrangements in intraductal carcinomas of salivary gland. Am J Surg Pathol. 2018;42(4):442–52.PubMedPubMedCentralCrossRef
35.
Zurück zum Zitat Bishop JA, Gagan J, Krane JF, Jo VY. Low-grade apocrine intraductal carcinoma: expanding the morphologic and molecular spectrum of an enigmatic salivary gland tumor. Head Neck Pathol. 2020;14(4):869–75.PubMedPubMedCentralCrossRef Bishop JA, Gagan J, Krane JF, Jo VY. Low-grade apocrine intraductal carcinoma: expanding the morphologic and molecular spectrum of an enigmatic salivary gland tumor. Head Neck Pathol. 2020;14(4):869–75.PubMedPubMedCentralCrossRef
36.
Zurück zum Zitat Leal C, Henrique R, Monteiro P, Lopes C, Bento MJ, De Sousa CP, et al. Apocrine ductal carcinoma in situ of the breast: histologic classification and expression of biologic markers. Hum Pathol. 2001;32(5):487–93.PubMedCrossRef Leal C, Henrique R, Monteiro P, Lopes C, Bento MJ, De Sousa CP, et al. Apocrine ductal carcinoma in situ of the breast: histologic classification and expression of biologic markers. Hum Pathol. 2001;32(5):487–93.PubMedCrossRef
37.
Zurück zum Zitat Robson A, Lazar AJ, Ben Nagi J, Hanby A, Grayson W, Feinmesser M, et al. Primary cutaneous apocrine carcinoma: a clinico-pathologic analysis of 24 cases. Am J Surg Pathol. 2008;32(5):682–90.PubMedCrossRef Robson A, Lazar AJ, Ben Nagi J, Hanby A, Grayson W, Feinmesser M, et al. Primary cutaneous apocrine carcinoma: a clinico-pathologic analysis of 24 cases. Am J Surg Pathol. 2008;32(5):682–90.PubMedCrossRef
38.
Zurück zum Zitat Vranic S, Marchiò C, Castellano I, Botta C, Scalzo MS, Bender RP, et al. Immunohistochemical and molecular profiling of histologically defined apocrine carcinomas of the breast. Hum Pathol. 2015;46(9):1350–9.PubMedCrossRef Vranic S, Marchiò C, Castellano I, Botta C, Scalzo MS, Bender RP, et al. Immunohistochemical and molecular profiling of histologically defined apocrine carcinomas of the breast. Hum Pathol. 2015;46(9):1350–9.PubMedCrossRef
39.
Zurück zum Zitat Weisman PS, Ng CK, Brogi E, Eisenberg RE, Won HH, Piscuoglio S, et al. Genetic alterations of triple negative breast cancer by targeted next-generation sequencing and correlation with tumor morphology. Mod Pathol. 2016;29(5):476–88.PubMedPubMedCentralCrossRef Weisman PS, Ng CK, Brogi E, Eisenberg RE, Won HH, Piscuoglio S, et al. Genetic alterations of triple negative breast cancer by targeted next-generation sequencing and correlation with tumor morphology. Mod Pathol. 2016;29(5):476–88.PubMedPubMedCentralCrossRef
40.
Zurück zum Zitat Cheuk W, Miliauskas JR, Chan JK. Intraductal carcinoma of the oral cavity: a case report and a reappraisal of the concept of pure ductal carcinoma in situ in salivary duct carcinoma. Am J Surg Pathol. 2004;28(2):266–70.PubMedCrossRef Cheuk W, Miliauskas JR, Chan JK. Intraductal carcinoma of the oral cavity: a case report and a reappraisal of the concept of pure ductal carcinoma in situ in salivary duct carcinoma. Am J Surg Pathol. 2004;28(2):266–70.PubMedCrossRef
41.
Zurück zum Zitat Simpson RH, Desai S, Di Palma S. Salivary duct carcinoma in situ of the parotid gland. Histopathology. 2008;53(4):416–25.PubMedCrossRef Simpson RH, Desai S, Di Palma S. Salivary duct carcinoma in situ of the parotid gland. Histopathology. 2008;53(4):416–25.PubMedCrossRef
42.
Zurück zum Zitat Skálová A, Vanecek T, Uro-Coste E, Bishop JA, Weinreb I, Thompson LDR, et al. Molecular profiling of salivary gland intraductal carcinoma revealed a subset of tumors harboring NCOA4-RET and novel TRIM27-RET fusions: a report of 17 cases. Am J Surg Pathol. 2018;42(11):1445–55.PubMedCrossRef Skálová A, Vanecek T, Uro-Coste E, Bishop JA, Weinreb I, Thompson LDR, et al. Molecular profiling of salivary gland intraductal carcinoma revealed a subset of tumors harboring NCOA4-RET and novel TRIM27-RET fusions: a report of 17 cases. Am J Surg Pathol. 2018;42(11):1445–55.PubMedCrossRef
43.
Zurück zum Zitat Skálová A, Ptáková N, Santana T, Agaimy A, Ihrler S, Uro-Coste E, et al. NCOA4-RET and TRIM27-RET are characteristic gene fusions in salivary intraductal carcinoma, including invasive and metastatic tumors: is “Intraductal” correct? Am J Surg Pathol. 2019;43(10):1303–13.PubMedCrossRef Skálová A, Ptáková N, Santana T, Agaimy A, Ihrler S, Uro-Coste E, et al. NCOA4-RET and TRIM27-RET are characteristic gene fusions in salivary intraductal carcinoma, including invasive and metastatic tumors: is “Intraductal” correct? Am J Surg Pathol. 2019;43(10):1303–13.PubMedCrossRef
44.
Zurück zum Zitat Bishop JA, Nakaguro M, Whaley RD, Ogura K, Imai H, Laklouk I, et al. Oncocytic intraductal carcinoma of salivary glands: a distinct variant with TRIM33-RET fusions and BRAF V600E mutations. Histopathology. 2020. Bishop JA, Nakaguro M, Whaley RD, Ogura K, Imai H, Laklouk I, et al. Oncocytic intraductal carcinoma of salivary glands: a distinct variant with TRIM33-RET fusions and BRAF V600E mutations. Histopathology. 2020.
45.
Zurück zum Zitat Katabi N, Ghossein R, Ho A, Dogan S, Zhang L, Sung YS, et al. Consistent PLAG1 and HMGA2 abnormalities distinguish carcinoma ex-pleomorphic adenoma from its de novo counterparts. Hum Pathol. 2015;46(1):26–33.PubMedCrossRef Katabi N, Ghossein R, Ho A, Dogan S, Zhang L, Sung YS, et al. Consistent PLAG1 and HMGA2 abnormalities distinguish carcinoma ex-pleomorphic adenoma from its de novo counterparts. Hum Pathol. 2015;46(1):26–33.PubMedCrossRef
46.
Zurück zum Zitat Chiosea SI, Thompson LD, Weinreb I, Bauman JE, Mahaffey AM, Miller C, et al. Subsets of salivary duct carcinoma defined by morphologic evidence of pleomorphic adenoma, PLAG1 or HMGA2 rearrangements, and common genetic alterations. Cancer. 2016;122(20):3136–44.PubMedCrossRef Chiosea SI, Thompson LD, Weinreb I, Bauman JE, Mahaffey AM, Miller C, et al. Subsets of salivary duct carcinoma defined by morphologic evidence of pleomorphic adenoma, PLAG1 or HMGA2 rearrangements, and common genetic alterations. Cancer. 2016;122(20):3136–44.PubMedCrossRef
47.
Zurück zum Zitat Williams L, Thompson LD, Seethala RR, Weinreb I, Assaad AM, Tuluc M, et al. Salivary duct carcinoma: the predominance of apocrine morphology, prevalence of histologic variants, and androgen receptor expression. Am J Surg Pathol. 2015;39(5):705–13.PubMedCrossRef Williams L, Thompson LD, Seethala RR, Weinreb I, Assaad AM, Tuluc M, et al. Salivary duct carcinoma: the predominance of apocrine morphology, prevalence of histologic variants, and androgen receptor expression. Am J Surg Pathol. 2015;39(5):705–13.PubMedCrossRef
48.
Zurück zum Zitat Bahrami A, Perez-Ordonez B, Dalton JD, Weinreb I. An analysis of PLAG1 and HMGA2 rearrangements in salivary duct carcinoma and examination of the role of precursor lesions. Histopathology. 2013;63(2):250–62.PubMedCrossRef Bahrami A, Perez-Ordonez B, Dalton JD, Weinreb I. An analysis of PLAG1 and HMGA2 rearrangements in salivary duct carcinoma and examination of the role of precursor lesions. Histopathology. 2013;63(2):250–62.PubMedCrossRef
49.
Zurück zum Zitat Seifert G, Thomsen S, Donath K. Bilateral dysgenetic polycystic parotid glands. Morphological analysis and differential diagnosis of a rare disease of the salivary glands. Virchows Arch A. 1981;390(3):273–88.CrossRef Seifert G, Thomsen S, Donath K. Bilateral dysgenetic polycystic parotid glands. Morphological analysis and differential diagnosis of a rare disease of the salivary glands. Virchows Arch A. 1981;390(3):273–88.CrossRef
50.
Zurück zum Zitat Batsakis JG, Bruner JM, Luna MA. Polycystic (dysgenetic) disease of the parotid glands. Arch Otolaryngol Head Neck Surg. 1988;114(10):1146–8.PubMedCrossRef Batsakis JG, Bruner JM, Luna MA. Polycystic (dysgenetic) disease of the parotid glands. Arch Otolaryngol Head Neck Surg. 1988;114(10):1146–8.PubMedCrossRef
51.
Zurück zum Zitat Hernandez-Prera JC, Skálová A, Franchi A, Rinaldo A, Vander Poorten V, Zbären P, et al. Pleomorphic adenoma: the great mimicker of malignancy. Histopathology. 2020. Hernandez-Prera JC, Skálová A, Franchi A, Rinaldo A, Vander Poorten V, Zbären P, et al. Pleomorphic adenoma: the great mimicker of malignancy. Histopathology. 2020.
52.
Zurück zum Zitat Wong KS, Mariño-Enriquez A, Hornick JL, Jo VY. NR4A3 immunohistochemistry reliably discriminates acinic cell carcinoma from mimics. Head Neck Pathol. 2021;15(2):425–32.PubMedCrossRef Wong KS, Mariño-Enriquez A, Hornick JL, Jo VY. NR4A3 immunohistochemistry reliably discriminates acinic cell carcinoma from mimics. Head Neck Pathol. 2021;15(2):425–32.PubMedCrossRef
53.
Zurück zum Zitat Bell D, El-Naggar AK. Molecular heterogeneity in mucoepidermoid carcinoma: conceptual and practical implications. Head Neck Pathol. 2013;7(1):23–7.PubMedPubMedCentralCrossRef Bell D, El-Naggar AK. Molecular heterogeneity in mucoepidermoid carcinoma: conceptual and practical implications. Head Neck Pathol. 2013;7(1):23–7.PubMedPubMedCentralCrossRef
54.
Zurück zum Zitat Tan MH, Mester J, Peterson C, Yang Y, Chen JL, Rybicki LA, et al. A clinical scoring system for selection of patients for PTEN mutation testing is proposed on the basis of a prospective study of 3042 probands. Am J Hum Genet. 2011;88(1):42–56.PubMedPubMedCentralCrossRef Tan MH, Mester J, Peterson C, Yang Y, Chen JL, Rybicki LA, et al. A clinical scoring system for selection of patients for PTEN mutation testing is proposed on the basis of a prospective study of 3042 probands. Am J Hum Genet. 2011;88(1):42–56.PubMedPubMedCentralCrossRef
55.
Zurück zum Zitat Villeneuve H, Tremblay S, Galiatsatos P, Hamel N, Guertin L, Morency R, et al. Acinic cell carcinoma of the retromolar trigone region: expanding the tumor phenotype in Cowden syndrome? Fam Cancer. 2011;10(4):691–4.PubMedCrossRef Villeneuve H, Tremblay S, Galiatsatos P, Hamel N, Guertin L, Morency R, et al. Acinic cell carcinoma of the retromolar trigone region: expanding the tumor phenotype in Cowden syndrome? Fam Cancer. 2011;10(4):691–4.PubMedCrossRef
56.
Zurück zum Zitat Jazaerly T, Bandyopadhyay S, Almardini N, Husain M. Diagnosis of sebaceous lymphadenoma by fine needle aspiration in a patient with Cowden syndrome: case report and review of the literature. Cytojournal. 2014;11:25.PubMedPubMedCentralCrossRef Jazaerly T, Bandyopadhyay S, Almardini N, Husain M. Diagnosis of sebaceous lymphadenoma by fine needle aspiration in a patient with Cowden syndrome: case report and review of the literature. Cytojournal. 2014;11:25.PubMedPubMedCentralCrossRef
57.
Zurück zum Zitat Viswanathan K, Maleki Z, Pantanowitz L, Cantley R, Faquin WC. Cytomorphology and diagnostic pitfalls of sebaceous and nonsebaceous salivary gland lymphadenoma: a multi-institutional study. Diagn Cytopathol. 2021;49(1):83–95.PubMedCrossRef Viswanathan K, Maleki Z, Pantanowitz L, Cantley R, Faquin WC. Cytomorphology and diagnostic pitfalls of sebaceous and nonsebaceous salivary gland lymphadenoma: a multi-institutional study. Diagn Cytopathol. 2021;49(1):83–95.PubMedCrossRef
59.
Zurück zum Zitat Yehia L, Keel E, Eng C. The clinical spectrum of PTEN mutations. Annu Rev Med. 2020;71:103–16.PubMedCrossRef Yehia L, Keel E, Eng C. The clinical spectrum of PTEN mutations. Annu Rev Med. 2020;71:103–16.PubMedCrossRef
60.
Zurück zum Zitat Landrum MJ, Chitipiralla S, Brown GR, Chen C, Gu B, Hart J, et al. ClinVar: improvements to accessing data. Nucleic Acids Res. 2020;48(D1):D835–44.PubMedCrossRef Landrum MJ, Chitipiralla S, Brown GR, Chen C, Gu B, Hart J, et al. ClinVar: improvements to accessing data. Nucleic Acids Res. 2020;48(D1):D835–44.PubMedCrossRef
61.
Zurück zum Zitat Manojlović S, Virag M, Milenović A, Manojlović L, Šalek Z, Skálová A. Sclerosing polycystic adenosis of parotid gland: a unique report of two cases occurring in two sisters. Pathology-Res Pract. 2014;210(6):342–5.CrossRef Manojlović S, Virag M, Milenović A, Manojlović L, Šalek Z, Skálová A. Sclerosing polycystic adenosis of parotid gland: a unique report of two cases occurring in two sisters. Pathology-Res Pract. 2014;210(6):342–5.CrossRef
62.
Zurück zum Zitat Lincoln SE, Nussbaum RL, Kurian AW, Nielsen SM, Das K, Michalski S, et al. Yield and utility of germline testing following tumor sequencing in patients with cancer. JAMA Netw Open. 2020;3(10):e2019452.PubMedPubMedCentralCrossRef Lincoln SE, Nussbaum RL, Kurian AW, Nielsen SM, Das K, Michalski S, et al. Yield and utility of germline testing following tumor sequencing in patients with cancer. JAMA Netw Open. 2020;3(10):e2019452.PubMedPubMedCentralCrossRef
Metadaten
Titel
Sclerosing Polycystic Adenoma: Conclusive Clinical and Molecular Evidence of Its Neoplastic Nature
verfasst von
Juan C. Hernandez-Prera
Daryoush Saeed-Vafa
Amin Heidarian
Kathleen Gewandter
Kristen Otto
Bruce M. Wenig
Publikationsdatum
19.08.2021
Verlag
Springer US
Erschienen in
Head and Neck Pathology / Ausgabe 2/2022
Elektronische ISSN: 1936-0568
DOI
https://doi.org/10.1007/s12105-021-01374-w

Weitere Artikel der Ausgabe 2/2022

Head and Neck Pathology 2/2022 Zur Ausgabe

Neu im Fachgebiet Pathologie

Assistierter Suizid durch Infusion von Thiopental

Thiopental Originalie

Als Folge des Urteils des Bundesverfassungsgerichts zur Sterbehilfe im Jahr 2020 wurde in den Jahren 2021–2023 eine Reihe (n = 23) von assistierten Suiziden im Landesinstitut für gerichtliche und soziale Medizin Berlin mit jeweils identischen …

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …